• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BPIFB4 长寿相关变体赋予亨廷顿病 STHdh 细胞模型中的神经保护作用。

Longevity-Associated Variant of BPIFB4 Confers Neuroprotection in the STHdh Cell Model of Huntington Disease.

机构信息

Cardiovascular Department, IRCCS MultiMedica, 20138 Milan, Italy.

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Salerno, Italy.

出版信息

Int J Mol Sci. 2022 Dec 5;23(23):15313. doi: 10.3390/ijms232315313.

DOI:10.3390/ijms232315313
PMID:36499641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9737551/
Abstract

Huntington's disease (HD) is caused by the production of mutant Huntingtin (mHTT), characterized by long polyglutamine repeats with toxic effects. There are currently no clinically validated therapeutic agents that slow or halt HD progression, resulting in a significant clinical unmet need. The striatum-derived STHdh cell line, generated from mHTT knock-in mouse embryos (STHdh), represents a useful model to study mechanisms behind pathogenesis of HD and to investigate potential new therapeutic targets. Indeed, these cells show susceptibility to nucleolar stress, activated DNA damage response and apoptotic signals, and elevated levels of H3K9me3 that all together concur in the progressive HD pathogenesis. We have previously shown that the adeno-associated viral vector-mediated delivery of the prevents HD progression in a mouse model of HD. Here, we show that LAV-BPIFB4 stably infected in STHdh cells reduces (i) nucleolar stress and DNA damage through the improvement of DNA repair machinery, (ii) apoptosis, through the inhibition of the caspase 3 death signaling, and (iii) the levels of H3K9me3, by accelerating the histone clearance, via the ubiquitin-proteasome pathway. These findings pave the way to propose LAV-BPIFB4 as a promising target for innovative therapeutic strategies in HD.

摘要

亨廷顿病(HD)是由突变亨廷顿蛋白(mHTT)的产生引起的,其特征是具有毒性作用的长聚谷氨酰胺重复序列。目前尚无临床验证的治疗药物能够减缓或阻止 HD 的进展,因此存在巨大的临床未满足需求。源自 mHTT 敲入小鼠胚胎的纹状体来源的 STHdh 细胞系(STHdh)是研究 HD 发病机制背后的机制和研究潜在新治疗靶点的有用模型。事实上,这些细胞对核仁应激、激活的 DNA 损伤反应和凋亡信号敏感,并且 H3K9me3 水平升高,所有这些都共同导致 HD 的进行性发病。我们之前已经表明,腺相关病毒载体介导的递送可以防止 HD 模型中的 HD 进展。在这里,我们表明,LAV-BPIFB4 稳定感染 STHdh 细胞可通过以下方式减少(i)核仁应激和 DNA 损伤:改善 DNA 修复机制;(ii)通过抑制半胱天冬酶 3 死亡信号来抑制细胞凋亡;以及(iii)通过泛素-蛋白酶体途径加速组蛋白清除,从而降低 H3K9me3 水平。这些发现为将 LAV-BPIFB4 作为 HD 创新治疗策略的有前途的靶标铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/fb1aeefab8a5/ijms-23-15313-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/9e5971bcf7ea/ijms-23-15313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/13bf0432f129/ijms-23-15313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/0ef8e836990a/ijms-23-15313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/700598aa2ba8/ijms-23-15313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/be1606887c67/ijms-23-15313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/fb1aeefab8a5/ijms-23-15313-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/9e5971bcf7ea/ijms-23-15313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/13bf0432f129/ijms-23-15313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/0ef8e836990a/ijms-23-15313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/700598aa2ba8/ijms-23-15313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/be1606887c67/ijms-23-15313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cbe/9737551/fb1aeefab8a5/ijms-23-15313-g006.jpg

相似文献

1
Longevity-Associated Variant of BPIFB4 Confers Neuroprotection in the STHdh Cell Model of Huntington Disease.BPIFB4 长寿相关变体赋予亨廷顿病 STHdh 细胞模型中的神经保护作用。
Int J Mol Sci. 2022 Dec 5;23(23):15313. doi: 10.3390/ijms232315313.
2
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum-microglia crosstalk preventing disease progression in a mouse model of Huntington's disease.与长寿相关的 BPIFB4 变体改善了 CXCR4 介导的纹状体-小胶质细胞串扰,从而防止亨廷顿病小鼠模型的疾病进展。
Cell Death Dis. 2020 Jul 18;11(7):546. doi: 10.1038/s41419-020-02754-w.
3
Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.亨廷顿舞蹈病小鼠纹状体细胞模型与对照的差异蛋白质组学和基因组分析;对疾病生物学的可能影响。
J Proteomics. 2016 Jan 30;132:155-66. doi: 10.1016/j.jprot.2015.11.007. Epub 2015 Nov 12.
4
Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.表达全长突变 huntingtin 的纹状体细胞对氧化应激反应受损与线粒体动力学和 Nrf2 信号转导受损有关。
PLoS One. 2013;8(3):e57932. doi: 10.1371/journal.pone.0057932. Epub 2013 Mar 1.
5
Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.Bim表达增加有助于亨廷顿病基因敲入纹状体细胞系中血清剥夺诱导的凋亡性细胞死亡的增强。
Neurol Res. 2009 Feb;31(1):77-83. doi: 10.1179/174313208X331572. Epub 2008 Aug 7.
6
Twist1 Plays an Anti-apoptotic Role in Mutant Huntingtin Expression Striatal Progenitor Cells.Twist1 在表达突变 huntingtin 的纹状体祖细胞中发挥抗凋亡作用。
Mol Neurobiol. 2020 Mar;57(3):1688-1703. doi: 10.1007/s12035-019-01836-x. Epub 2019 Dec 7.
7
Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.翻译:核糖体 S6 激酶 90kDa 亚型(Rsk)活性升高可对抗突变型亨廷顿毒性。
Mol Neurodegener. 2011 Oct 31;6:74. doi: 10.1186/1750-1326-6-74.
8
Delayed Cell Cycle Progression in STHdh(Q111)/Hdh(Q111) Cells, a Cell Model for Huntington's Disease Mediated by microRNA-19a, microRNA-146a and microRNA-432.STHdh(Q111)/Hdh(Q111)细胞中细胞周期进展延迟,这是一种由微小RNA-19a、微小RNA-146a和微小RNA-432介导的亨廷顿舞蹈症细胞模型。
Microrna. 2015;4(2):86-100. doi: 10.2174/2211536604666150713105606.
9
Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model.抑制p38丝裂原活化蛋白激酶可改善亨廷顿病模型中HAP40缺失诱导的毒性和蛋白酶体缺陷。
Mol Neurobiol. 2021 Jun;58(6):2704-2723. doi: 10.1007/s12035-020-02280-y. Epub 2021 Jan 25.
10
Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.Elk-1 的激活作为一种神经保护的代偿机制参与亨廷顿病模型。
J Neurochem. 2012 May;121(4):639-48. doi: 10.1111/j.1471-4159.2012.07711.x. Epub 2012 Mar 28.

引用本文的文献

1
The Genetic and Epigenetic Arms of Human Ageing and Longevity.人类衰老与长寿的遗传及表观遗传因素
Biology (Basel). 2025 Jan 18;14(1):92. doi: 10.3390/biology14010092.
2
mA modification of mutant huntingtin RNA promotes the biogenesis of pathogenic huntingtin transcripts.mA 修饰突变型亨廷顿 RNA 促进致病性亨廷顿转录本的生物发生。
EMBO Rep. 2024 Nov;25(11):5026-5052. doi: 10.1038/s44319-024-00283-7. Epub 2024 Oct 11.
3
Neurodegenerative Diseases: Molecular Mechanisms and Therapies.神经退行性疾病:分子机制与治疗。

本文引用的文献

1
The role of histone modifications: from neurodevelopment to neurodiseases.组蛋白修饰的作用:从神经发育到神经疾病。
Signal Transduct Target Ther. 2022 Jul 6;7(1):217. doi: 10.1038/s41392-022-01078-9.
2
Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38 macrophages and NAD decline.BPIFB4 基因长寿相关变异的转移通过减少 CD38 巨噬细胞和 NAD 下降来恢复免疫系统和血管。
Cell Death Dis. 2022 Jan 27;13(1):86. doi: 10.1038/s41419-022-04535-z.
3
Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model.
Int J Mol Sci. 2023 Sep 6;24(18):13721. doi: 10.3390/ijms241813721.
4
BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and mice.BPIFB4 及其与长寿相关的单倍型可保护人类和小鼠免受心肌缺血的影响。
Cell Death Dis. 2023 Aug 15;14(8):523. doi: 10.1038/s41419-023-06011-8.
5
Effects of Human LAV-BPIFB4 Gene Therapy on the Epigenetic Clock and Health of Aged Mice.人类 LAV-BPIFB4 基因治疗对老年小鼠的表观遗传钟和健康的影响。
Int J Mol Sci. 2023 Mar 30;24(7):6464. doi: 10.3390/ijms24076464.
APQ 通过调控 SETDB1 的活性改善亨廷顿病小鼠模型的异染色质凝聚、运动功能和神经病理学。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):856-868. doi: 10.1080/14756366.2021.1900160.
4
The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum-microglia crosstalk preventing disease progression in a mouse model of Huntington's disease.与长寿相关的 BPIFB4 变体改善了 CXCR4 介导的纹状体-小胶质细胞串扰,从而防止亨廷顿病小鼠模型的疾病进展。
Cell Death Dis. 2020 Jul 18;11(7):546. doi: 10.1038/s41419-020-02754-w.
5
Epigenetic deregulation of lamina-associated domains in Hutchinson-Gilford progeria syndrome.亨廷顿病样 2 型早发型进行性肌阵挛性癫痫症患者中核纤层蛋白相关结构域的表观遗传失调。
Genome Med. 2020 May 25;12(1):46. doi: 10.1186/s13073-020-00749-y.
6
Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer's disease.组蛋白 H3K9me3 塑造的表观基因组特征与阿尔茨海默病中的突触功能障碍有关。
Aging Cell. 2020 Jun;19(6):e13153. doi: 10.1111/acel.13153. Epub 2020 May 17.
7
Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF-1/CXCR4 signalling pathway.携带与人长寿相关基因变异的人类细胞,通过诱导 SDF-1/CXCR4 信号通路,改善肥胖 2 型糖尿病小鼠的心脏功能。
Eur J Heart Fail. 2020 Sep;22(9):1568-1581. doi: 10.1002/ejhf.1840. Epub 2020 May 8.
8
LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice.LAV-BPIFB4与人类虚弱程度降低相关,其转移可防止老年小鼠的虚弱进展。
Aging (Albany NY). 2019 Aug 28;11(16):6555-6568. doi: 10.18632/aging.102209.
9
Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism.单次系统性转移与人长寿相关的基因通过 CXCR4 介导的机制可阻止 ApoE 基因敲除小鼠动脉粥样硬化和炎症的进展。
Eur Heart J. 2020 Jul 7;41(26):2487-2497. doi: 10.1093/eurheartj/ehz459.
10
Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.亨廷顿病相关行为、细胞和病理特征的促进:亨廷顿病基因缺失在神经节内侧和外侧谱系中差异破坏区域中间神经元和投射神经元亚型。
J Neurosci. 2019 Mar 6;39(10):1892-1909. doi: 10.1523/JNEUROSCI.2443-18.2018. Epub 2019 Jan 9.